In the coming years, it is expected that the Global Cancer Immunotherapy Market will advance with higher growth rate as compared to previous years. Rising pressure to curb healthcare costs has fuelled the growth of the market for Cancer Immunotherapy market.
Pune, India -- (SBWIRE) -- 01/09/2018 -- "Americas Cancer Immunotherapy Market by Manufacturers, Countries, Type and Application, Forecast to 2023 Report "Provides In-Depth Analysis of Parent Market Trends, Macro-Economic Indicators and Governing Factors Along With Market Attractiveness as Per Segments. The Americas cancer immunotherapy market is expected to grow at an approximate CAGR of 10.1% during the forecast period.
GET SAMPLE REPORT @ https://www.marketresearchfuture.com/sample_request/592 .
MarketResearchFuture.com adds "Cancer Immunotherapy Market -2017 Americas Analysis, Growth, Trends and Opportunities Research Report Forecasting to 2023" reports to its database.
Market Scenario of Americas Cancer Immunotherapy Market:
Cancer Immunotherapy is a treatment that uses a person's immune system to fight the diseases. Some types of the cancer immunotherapies are often referred to as biologic therapies or biotherapies. The basic principle of cancer immunotherapy is to enhance a patient's immune system to fight against cancer. This can be achieved by administrating various immune system components, such as synthesized immune proteins. In recent years, cancer immunotherapy have been extensively exploited for the treatment of the different type cancers including breast, prostate, lung cancer, and others. Increasing prevalence of cancer is one of the major drivers for the market growth during the forecast period. The most commonly prevalent cancers in the U.S. include breast cancer, lung, bronchus cancer, and others. According to the National Cancer Institute in 2016, an estimated 1,685,210 new cases of cancer were diagnosed in the U.S. and approximately 595,690 people died due to cancer within the region. Moreover, it was estimated that the national healthcare expenditures for cancer care in the U.S. totalled nearly to USD 125 billion in 2010, and it is expected to reach USD 156 billion by 2020. Moreover, growing geriatric population and rising healthcare expenditure will boost the market growth. Additionally, growing biotech and pharmaceutical industries fuels the market growth during the projected period. However, lack of awareness, restriction in therapeutics against different cancers and high cost for the treatment may restrain the market growth from 2017-2023.
Key players for the Americas Cancer Immunotherapy Market
Some of the major player in the market are Amgen Inc. (U.S.), AstraZeneca (U.K), F. Hoffmann-La Roche Ltd. (Switzerland), Bayer AG (Germany), Bristol-Myers Squibb Company (U.S.), Eli Lilly and Company (U.S.), Merck & Co., Inc. (U.S.), Pfizer Inc. (U.S.), Novartis AG (Switzerland), and others.
Segmentation of Americas Cancer Immunotherapy Market:
The Americas cancer immunotherapy market is segmented on the basis of cancer, therapeutics, and end users.
On the basis of the cancer, the market is segmented into lung cancer, prostate cancer, colorectal cancer, head & neck cancer, and others.
On the basis of the therapeutics, the market is segmented into monoclonal antibodies, immune checkpoint inhibitors, vaccines, non-specific cancer immunotherapies and adjuvants, and others. The monoclonal antibodies segment is sub segmented into naked monoclonal antibodies, conjugated monoclonal antibodies, chemolabeled antibodies, bispecific monoclonal antibodies, and others. The naked monoclonal antibodies segment, by monoclonal antibody segment, is father segmented into alemtuzumab, trastuzumab, and others. The immune checkpoint inhibitors segment is sub segmented into PD-1 inhibitors, PD-L1 inhibitors, and others. The PD-1 inhibitors segment, by immune checkpoint inhibitors, is sub segmented into pembrolizumab, nivolumab, and others. The PD-L1 inhibitors segment, by immune checkpoint inhibitors, is further segmented into atezolizumab, avelumab, and others. The non-specific cancer immunotherapies and adjuvants segment is sub segmented into cytokines, interleukins, and others.
On the basis of the end users, the market is segmented as hospitals & clinics, academic institutes, research organization, and others.
GET FULL REPORT @ https://www.marketresearchfuture.com/reports/cancer-immunotherapy-market-592 .
Regional Analysis of Americas Cancer Immunotherapy Market:
On regional basis the Americas is divided into North America and Latin America. North America is sub segmented into U.S. and Canada. North America commands for the largest market share for the Americas cancer immunotherapy market due the presence of the U.S. within the region. This large share is also attributed due to the technologically advanced healthcare market in the region which is followed by high prevalence of cancer, increasing development in cancer immunotherapy treatment and rising per capita healthcare expenditure. Moreover, growing biotechnology, healthcare and life sciences sector within the region fuels the market growth regionally. The total number of the biotechnology industries in the U.S. increased from 2,763 in 2014 and reached 2,772 in 2015. Additionally, the abundance of state of the art laboratories in the U.S. is also facilitating the market growth.
On the other hand, Latin America is the fastest growing region due to the presence of the developing economies within the region, rising healthcare expenditure and huge patient population.
Major TOC of Americas Cancer Immunotherapy Market:
Chapter 1. Report Prologue
Chapter 2. Market Introduction
Chapter 3. Research Methodology
Chapter 4. Market Dynamics
Chapter 5. Market Factor Analysis
Chapter 6. The Americas Cancer Immunotherapy Market, By Cancer
Chapter 7. The Americas Cancer Immunotherapy Market, By Therapeutics
Chapter 8. The Americas Cancer Immunotherapy Market, By End Users
Chapter 9. The Americas Cancer Immunotherapy Market, By Region
Chapter 10. Company Landscape
Chapter 11. Company Profiles
Chapter 12. MRFR Conclusion
Chapter 13. Appendix
List Of Tables:
Table 1 The Americas Cancer Immunotherapy Industry Synopsis, 2017 – 2023
Table 2 Americas Cancer Immunotherapy Market Estimates And Forecast, 2017 – 2023, (USD Million)
Table 3 Americas Cancer Immunotherapy Market By Region, 2017 – 2023, (USD Million)
Table 4 The Americas Cancer Immunotherapy Market By Cancer, 2017 – 2023, (USD Million)
Table 5 The Americas Cancer Immunotherapy Market By Therapeutics, 2017 – 2023, (USD Million)
Table 6 The Americas Cancer Immunotherapy Market By End Users, 2017 – 2023, (USD Million)
List Of Figures:
Figure 1 Research Process
Figure 2 Segmentation For The Americas Cancer Immunotherapy Market
Figure 3 Market Dynamics For The Americas Cancer Immunotherapy Market
Figure 4 The Americas Cancer Immunotherapy Market Share, By Cancer 2016
Figure 5 The Americas Cancer Immunotherapy Market Share, By Therapeutics 2016
Figure 6 The Americas Cancer Immunotherapy Market Share, By End Users, 2016
...CONTINUED
GET DISCOUNT @ https://www.marketresearchfuture.com/check-discount/592 .
About Market Research Future
At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by products, services, technologies, applications, end users, and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.
Contact:
Market Research Future
Office No. 528, Amanora Chambers
Magarpatta Road, Hadapsar,
Pune - 411028
Maharashtra, India
+1 646 845 9312
Email: salesteam@marketresearchfuture.com